PT
Autoridade da Concorrência

Case details

Print
Merger control
Case reference
Ccent/2023/1 - BSC / Apollo
Acquired
Apollo Endosurgery, Inc.
Description
Company active in the development and sale of endoscopic devices for gastrointestinal applications. In Portugal, Apollo is active in the supply of intragastric balloons and endoscopic suture devices.
Acquiring
Boston Scientific Corporation
Description
Company active in the development, manufacture and sale of medical devices for medical intervention specialties, including intervention in cardiology, endovascular intervention, electrophysiology, endoscopy, radiology/oncology, urology, pulmonary endoscopy and neuromodulation.
Sector
  • Health & Pharmaceutical
Activity (NACE)
  • G4646 - Wholesale of pharmaceutical goods
Applicable legislation
Art. 37(1)(a) (Law 19)
Notification thresholds
Market Share threshold
Type of merger
Conglomerate
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Non-opposition
Case description

The notified concentration consists of the acquisition of Apollo Endosurgery by Boston Scientific Corporation.
Timeline
2023-03-14
The AdC issued a non-opposition decision to the merger 1/2023 - BSC / Apollo.
2023-01-20
Boston Scientific Corporation notifies the acquisition of Apollo Endosurgery.
Click here to see your activities